AZU1
AZU1 (azurocidin 1) is a neutrophil azurophil granule glycoprotein with antibacterial and monocyte chemotactic activity. It is also known as azurocidin, CAP37, HBP, AZU, AZAMP, NAZC and HUMAZUR, and acts as a multifunctional inflammatory mediator. Browse Assay Genie's current range of AZU1 research reagents below, or read on for the biology behind the target.
AZU1 encodes azurocidin, an antibacterial and chemotactic glycoprotein derived from neutrophil granules. It is chemotactic specifically for monocytes and fibroblasts, and it may help mediate the recruitment of monocytes in the second wave of inflammation. It also binds heparin. Its cytotoxic action is limited to many species of Gram-negative bacteria. This specificity may reflect the strong affinity of its very basic N-terminal half for the lipopolysaccharides (LPS) unique to the Gram-negative outer envelope.
Antibacterial activity has been described against the Gram-negative bacterium P. aeruginosa, and LPS from P. aeruginosa inhibits it. Acting alone, azurocidin shows no antimicrobial activity against several other Gram-negative species, including E. coli ML-35. It does act synergistically with either elastase or cathepsin G against C. sputigena ATCC 33123. The gene produces a preproprotein, which is proteolytically processed into the mature azurophil granule antibiotic protein. The mature protein localises to the cytoplasmic granule membrane.
Azurocidin belongs to the peptidase S1 family, elastase subfamily, and HGNC places the gene in the group of granule associated serine proteases of immune defence. It is not a functional serine proteinase, because the active site serine and histidine residues are replaced. The AZU1 gene lies in a cluster with the genes for neutrophil elastase 2 and proteinase 3. All three are expressed coordinately, and their products are packaged together into azurophil granules, specialised lysosomes of the neutrophil, during neutrophil differentiation. The name HBP is an alias for the protein, and CAP37 is another.
Azurocidin is packaged into azurophil granules during neutrophil differentiation, alongside neutrophil elastase 2 and proteinase 3.
It shows antibacterial activity towards Gram-negative bacteria, with specificity attributed to its affinity for lipopolysaccharide.
AZU1 is a multifunctional inflammatory mediator that is chemotactic for monocytes and may contribute to their recruitment in the second wave of inflammation.
Azurocidin is a catalytically inactive member of the serine protease family, with its active site serine and histidine residues replaced.
AZU1 encodes azurocidin, a neutrophil granule-derived antibacterial glycoprotein. It is chemotactic for monocytes and fibroblasts, binds heparin, and kills many Gram-negative bacteria. It may help recruit monocytes during the second wave of inflammation.
No. Azurocidin belongs to the peptidase S1 family, elastase subfamily, but it is not a serine proteinase. Its active site serine and histidine residues are replaced. It still contributes antimicrobial and inflammatory functions, and it can act synergistically with elastase or cathepsin G.
The AZU1 gene (azurocidin 1) is also called AZU, CAP37, AZAMP, HBP, NAZC and HUMAZUR. The protein is called azurocidin. The gene sits in a cluster with the neutrophil elastase 2 and proteinase 3 genes, which are expressed coordinately.
Neutrophil granule proteases and other innate immune defence proteins that act alongside azurocidin.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P20160; product specifications from Assay Genie datasheets.